Abstract
IntroductionNon-Hodgkin’s lymphomas (NHL) represent about 5%of all cancers. They are mostly nodal, although extra-nodal involvement is diagnosed in 26–40% of cases.NK/T-cell lymphoma – nasal type, is a rare primarycutaneous variant of NHL being recognized as an inde-pendent entity in mature T-cell and NK neoplasm groupof the World Health Organization (WHO)/EuropeanOrganization for Research and Treatment of Cancer(EORTC) classification for cutaneous lymphomas. Theyare characterized by specific geographic predominancewithin Asia and South America, Epstein–Barr virus (EBV)infection and aggressive and destructive course with poorprognosis is observed even in cases with a fast diagnosisand an optimal treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
